So the Dec 7th R&D update appears to have been for
Post# of 148152
And the voluntary withdrawal of BLA for HIV-MDR Due to CRO data management Issues would have been with full knowledge of the mess.
I would say that CA appears to have really spent this last 6 months cleaning up. Leronlimab is still there so let's now go to work on a partnership and move on and get LL into doctors hands.